Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

612 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy.
Sebastian NT, Goyal S, Liu Y, Dhere V, Jani AB, Hershatter B, Patel PR, Shelton JW, Hanasoge S, Godette KD, Patel SA. Sebastian NT, et al. Among authors: patel sa. J Contemp Brachytherapy. 2024 Aug;16(4):268-272. doi: 10.5114/jcb.2024.143130. Epub 2024 Sep 12. J Contemp Brachytherapy. 2024. PMID: 39628817 Free PMC article.
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.
Fischer-Valuck BW, Rao YJ, Brenneman RJ, Patel PR, Filson CP, Jani AB, Liu Y, Goyal S, Xu K, Weiss A, Kucuk O, Cimmino C, Szabo S, Rossi P, Baumann BC, Pattaras J, Hershatter B, Patel SA. Fischer-Valuck BW, et al. Among authors: patel sa, patel pr. Brachytherapy. 2020 Sep-Oct;19(5):557-566. doi: 10.1016/j.brachy.2020.05.007. Epub 2020 Jul 3. Brachytherapy. 2020. PMID: 32624405
Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy.
Patel SA, Goyal S, Liu Y, Moghanaki D, Patel PR, Hanasoge S, Dhere VR, Shelton JW, Godette KD, Jani AB, Hershatter B, Fischer-Valuck BW. Patel SA, et al. Among authors: patel pr. JAMA Netw Open. 2020 Dec 1;3(12):e2025143. doi: 10.1001/jamanetworkopen.2020.25143. JAMA Netw Open. 2020. PMID: 33301015 Free PMC article.
Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer.
Dhere VR, Fischer-Valuck BW, Goyal S, Liu Y, Morgan TM, Ghavidel E, Moghanaki DM, Hershatter BW, Patel PR, Jani AB, Godette KD, Rossi PJ, Patel SA. Dhere VR, et al. Among authors: patel sa, patel pr. Brachytherapy. 2021 Nov-Dec;20(6):1130-1138. doi: 10.1016/j.brachy.2021.07.005. Epub 2021 Aug 18. Brachytherapy. 2021. PMID: 34417136
Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer.
McCall NS, Liu Y, Patel SA, Hershatter B, Moghanaki D, Godette KD, Hanasoge S, Patel P, Fischer-Valuck BW, Shelton JW, Jani AB. McCall NS, et al. Among authors: patel sa, patel p. Adv Radiat Oncol. 2021 Sep 10;6(6):100803. doi: 10.1016/j.adro.2021.100803. eCollection 2021 Nov-Dec. Adv Radiat Oncol. 2021. PMID: 34703954 Free PMC article.
Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy.
Sebastian N, Goyal S, Liu Y, Janopaul-Naylor JR, Patel PR, Dhere VR, Hanasoge S, Shelton JW, Godette KD, Jani AB, Hershatter B, Fischer-Valuck B, Patel SA. Sebastian N, et al. Among authors: patel sa, patel pr. JAMA Netw Open. 2023 Aug 1;6(8):e2327637. doi: 10.1001/jamanetworkopen.2023.27637. JAMA Netw Open. 2023. PMID: 37552479 Free PMC article.
612 results